Our work is focused on advancing sarcopenia screening through evidence-based medicine, AI-assisted assessment, and clinical collaboration.
MuscleIntelligence is designed around clinical data analysis and validation principles to support earlier detection of sarcopenia risk. Our research direction includes evaluating AI-assisted screening performance against established clinical indicators such as strength, function, body measurements, and health background.
We follow current research and guidelines in geriatrics, nutrition, functional performance, and muscle health to inform our screening approach. The platform is structured to support repeat assessments, risk trend review, and practical clinical interpretation.
We are building toward a research library that can include validation findings, model performance summaries, and clinically relevant publications related to sarcopenia detection, prevention, and monitoring.
Future clinical trial work may evaluate how AI-assisted risk assessment supports earlier identification, patient follow-up, and intervention planning across clinical and community settings.
Our goal is to collaborate with healthcare providers, academic researchers, and clinical partners to improve patient outcomes over time through better screening, clearer risk communication, and evidence-based care pathways.